J1576 HCPCS code: Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg

J1576 is the HCPCS Level II code for injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg. In 2024 Medicare paid an average of $51.78 per service for J1576 across 651,759 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 600 per day on outpatient hospital claims. Medicare volume rose 129% from 2023 to 2024 (285,062 to 651,759 services). In 2024, 126 suppliers billed Medicare for J1576 (purchases), serving 360 beneficiaries; Texas, Florida, California accounted for 28% of services.

Code details

FieldValue
SectionJ codes — Drugs administered other than oral method
Coverage codeD — Special coverage instructions apply
Pricing indicator51 — Drug or biological (priced per ASP/average sales price rules)
BETOS categoryO1E — Other drugs
Added2023-07-01
Last action effective2023-07-01

Who bills J1576 (2024)

MeasureValue
Suppliers billing rentals—
Suppliers billing purchases126
Referring clinicians313
Medicare beneficiaries360
States with claims40
Share of services in top 3 states (Texas, Florida, California)28%
YearSuppliersBeneficiaries
2023119391
2024126360

Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.

Medicare utilization for J1576, 2023–2024

YearServicesBeneficiariesAvg. allowedAvg. paid
2023285,062468$64.20$51.15
2024651,759668$65.03$51.78

States with the most J1576 services (2024)

StateServicesAvg. paid
Tennessee137,375$52.95
Texas111,970$51.37
Arizona62,900$50.15
Maryland58,580$52.48
Florida39,373$51.01

NCCI unit limits (MUE)

Claim typeMax units per dayRationale
outpatient hospital claims600Prescribing Information
practitioner claims600Prescribing Information

Medicare policy articles for this code

Covered diagnoses (412 ICD-10-CM codes)

The diagnoses most often listed as covered in the policy articles above:

ICD-10-CMDiagnosisArticles listing it
D80.0Hereditary hypogammaglobulinemia6
D80.2Selective deficiency of immunoglobulin A [IgA]6
D80.3Selective deficiency of immunoglobulin G [IgG] subclasses6
D80.4Selective deficiency of immunoglobulin M [IgM]6
D80.5Immunodeficiency with increased immunoglobulin M [IgM]6
D80.6Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia6
D80.7Transient hypogammaglobulinemia of infancy6
D81.0Severe combined immunodeficiency [SCID] with reticular dysgenesis6
D81.1Severe combined immunodeficiency [SCID] with low T- and B-cell numbers6
D81.2Severe combined immunodeficiency [SCID] with low or normal B-cell numbers6

Showing 10 of 412. The full list, non-covered diagnoses and CSV export are in Caduvo.

What changed for J1576

Frequently asked questions

What is HCPCS code J1576?

J1576 is the HCPCS Level II code for injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg. Short descriptor: "Inj, panzyga, 500 mg".

How much does Medicare pay for J1576?

In 2024, the average Medicare payment was $51.78 per service (average allowed $65.03).

Does Medicare cover J1576?

Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.

Which diagnoses support coverage for J1576?

Medicare policy articles that cite J1576 list 412 covered ICD-10-CM diagnosis codes across 6 articles. The most cited include D80.0 (Hereditary hypogammaglobulinemia), D80.2 (Selective deficiency of immunoglobulin A [IgA]), D80.3 (Selective deficiency of immunoglobulin G [IgG] subclasses). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.

How many units of J1576 can be billed per day?

600 on outpatient hospital claims; 600 on practitioner claims (NCCI medically unlikely edits).

Related J15 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.

All J codes · HCPCS lookup